Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

PharmaLundensis

Less than 1K followers
Overview
Ownership
Investor views
All
Press releases
ShowingAll content types

Press release2026-07-03 11:10

Sista chansen att följa med på PharmaLundensis resa

PharmaLundensis
Press release2026-07-01 14:38

PharmaLundensis: Information kring bolagets finansieringsstrategi

PharmaLundensis
Press release2026-06-30 14:48

PharmaLundensis: Phal-501 binder tungmetaller mycket effektivare än IodoCarb

PharmaLundensis

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release2026-06-30 14:07

PharmaLundensis: Frivillig avnotering har godkänts, sista dag för handel blir 14 juli

PharmaLundensis
Press release2026-06-29 16:16

PharmaLundensis: Komplettering till Information om kommande företrädesemission

PharmaLundensis
Press release2026-06-29 13:49

PharmaLundensis: Information om kommande företrädesemission

PharmaLundensis
Press release2026-06-25 18:16

PharmaLundensis: Kommuniké från årsstämma

PharmaLundensis
Press release2026-06-04 14:07

PharmaLundensis: Komplettering till Årsredovisning för 2025

PharmaLundensis
Regulatory press release2026-06-04 13:05

Årsredovisning för PharmaLundensis AB (publ) 556708-8074 Räkenskapsåret 2025-01-01 - 2025-12-31

PharmaLundensis
Regulatory press release2026-05-28 16:10

PharmaLundensis: Kvartalsrapport 2026-01-01 till 2026-03-31

PharmaLundensis
Press release2026-05-21 21:02

Kallelse till årsstämma i PharmaLundensis AB

PharmaLundensis
Press release2026-05-20 10:03

PharmaLundensis: Senarelägger Q1 rapport till torsdag den 28 Maj

PharmaLundensis
Press release2026-04-20 12:23

PharmaLundensis: Tidsplan för frivillig avnotering av aktie från Spotlight

PharmaLundensis
Press release2026-04-17 17:27

PharmaLundensis: Vidare information kring avnotering av aktie från Spotlight

PharmaLundensis
Press release2026-03-30 19:58

PharmaLundensis: Publicering av uppdaterad Internationell Affärsplan

PharmaLundensis
Press release2026-03-30 10:49

PharmaLundensis: Huvudägare kommer föreslå avnotering av aktie från Spotlight

PharmaLundensis
Press release2026-03-17 15:45

PharmaLundensis: Presenterar internationell Affärsplan

PharmaLundensis
Press release2026-03-17 13:42

PharmaLundensis: Registrering av företrädesemission hos Bolagsverket klar

PharmaLundensis
Regulatory press release2026-02-23 16:38

PharmaLundensis: Nyemission tecknades för ca 2,14 miljoner kronor

PharmaLundensis
Press release2026-02-05 14:27

PharmaLundensis: Publicering av emissionshandlingar och start av teckningstid

PharmaLundensis